Congratulations! You now have unlimited access to all articles from The Ophthalmologist.
Complete your profile at your earliest convenience to unlock the rest of your benefits:
relevant and personalised updates about your field
access to Case Studies/product profiles
digital magazine subscription
Welcome to our January/February issue of The Ophthalmologist. Our Upfront section covers everything from identifying the diagnostic challenges of Long COVID to increased access to glaucoma screening in low income countries. In our In My View Section, we hear from Rachel Reinhardt on why optometric scope expansion bills endanger patient safety and John W. Kitchens on why ultra-widefield imaging is essential for all. Our feature, “Landmark Literature'' explores the literature and research from all around the world that has shaped ophthalmology over the last 12 months. In the Anterior Segment section, we cover the development of a new peptide treatment for dry eye disease. In the retina section, we discuss a new tomography device that changes the scope for retinal and choroidal imaging. In the glaucoma pages, we cover the molecular effects of aging with a new model of glaucoma. In our profession section, Noha Ekdawi discusses the importance of outdoor time for preventing myopia in children. This is followed by our concluding “Sitting Down With…” feature, talking with the CEO of Lexitas Pharma Services, George Magrath. We hope you enjoy reading this issue of The Ophthalmologist!